Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

The most common cause of death in patients with acute myeloid leukemia (AML) who receive allogeneic hematopoietic stem cell transplantation (allo-HSCT) is AML relapse. Therefore, additive therapies post allo-HSCT have significant potential to prevent relapse. Natural killer (NK)-cell-based immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Norimichi, Nakamaki, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539946/
https://www.ncbi.nlm.nih.gov/pubmed/31027331
http://dx.doi.org/10.3390/ijms20092057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539946/
https://www.ncbi.nlm.nih.gov/pubmed/31027331
http://dx.doi.org/10.3390/ijms20092057

Ejemplares similares